LCN2 and myeloid sarcoma: Chronic microglial activation and sustained LCN2 production contribute to the inflammatory milieu in multiple sclerosis (MS) 5, while in Alzheimer's disease (AD), microglial activation and LCN2 production are linked to neuroinflammation and neuronal damage 6.